Skip to main content
Fig. 2 | BMC Nephrology

Fig. 2

From: The use of eculizumab in gemcitabine induced thrombotic microangiopathy

Fig. 2

a Demonstration of serum creatinine levels in relation to time since initiation of gemcitabine therapy and different interventions. b Demonstration of platelets level in relation to time since initiation of gemcitabine therapy and different interventions. c Demonstration of LDH level in relation to time since initiation of gemcitabine therapy and different interventions. HD – hemodialysis

Back to article page